Position in SRRK
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$346,665
+$36,810 QoQ
Shares Held
6,303
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#196
of 302 holders
Holding Since
Dec 2023
11 quarters on record
Common Shares in SRRK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Spire Wealth Management holds $7,680,555 across 34 Biotechnology names. SRRK ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
16,140 | $3,022,698 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,953 | $970,113 | |
| 3 | ARGX |
Argenx SE
|
914 | $847,981 | |
| 4 | NTLA |
Intellia Therapeutics, Inc.
|
39,516 | $668,610 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
7,144 | $559,160 | |
| 6 | EXEL |
Exelixis, Inc.
|
8,794 | $478,481 | |
| 7 | SRRK |
Scholar Rock Holding Corp
This page
|
6,303 | $346,665 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
1,000 | $152,820 |
All Filings in SRRK
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $346,665 | 6,303 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $309,855 | 6,303 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $416,492 | 9,455 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $352,104 | 9,455 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $334,896 | 9,455 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $303,978 | 9,455 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $408,645 | 9,455 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $75,734 | 9,455 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $78,760 | 9,455 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $167,920 | 9,455 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $177,754 | 9,455 | Shares | Sole | 2024-02-06 | |
| No filing history on record for this holder in this stock. | ||||||